Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
Holding LRMR?
Track your performance easily

Larimar Therapeutics (LRMR) Financial Statements

390 Followers

Larimar Therapeutics Financial Overview

Larimar Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.115; its P/E ratio is -6.14; Larimar Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.60M$ -16.73M$ -14.16M$ -9.06M$ -8.37M
EBITDA$ -24.51M$ -16.65M$ -14.08M$ -9.55M$ -8.32M
Net Income Common Stockholders$ -21.63M$ -14.65M$ -13.02M$ -9.06M$ -8.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 226.06M$ 227.30M$ 86.79M$ 95.59M$ 104.20M
Total Assets$ 237.16M$ 248.21M$ 95.94M$ 103.95M$ 111.72M
Total Debt$ 5.59M$ 5.34M$ 5.55M$ 5.39M$ 5.08M
Net Debt$ -220.47M$ -221.95M$ -81.24M$ -90.20M$ -99.12M
Total Liabilities$ 25.76M$ 17.36M$ 14.21M$ 11.24M$ 11.79M
Stockholders Equity$ 211.44M$ 230.85M$ 81.72M$ 92.71M$ 99.93M
Cash Flow-
Free Cash Flow$ -14.26M$ -10.41M$ -9.51M$ -9.20M$ -7.37M
Operating Cash Flow$ -13.99M$ -10.41M$ -9.34M$ -9.20M$ -7.37M
Investing Cash Flow$ -63.49M$ -68.36M$ -2.63M$ -46.43M$ -9.84M
Financing Cash Flow$ -334.00K$ 162.15M-$ 30.00K-
Currency in USD

Larimar Therapeutics Earnings and Revenue History

Larimar Therapeutics Debt to Assets

Larimar Therapeutics Cash Flow

Larimar Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis